Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here


Trehalose is a non-reducing disaccharide consisting of two glucose molecules linked by an α, α–1,1 bond.

Pfanstiehl brand high-purity low endotoxin (HPLE) Trehalose is used in the biopharmaceutical industry to stabilise proteins, lipids, and carbohydrates throughout the formulation and freeze / thaw lifecycle of therapeutics.

It is also widely applied as a key component in cryopreservation / freeze media to stabilise cell membranes and improve the recovery and robustness of cells used for bioproduction and cell therapy.

The stabilising benefits of trehalose include but are not limited to:

•   Monoclonal antibodies (mAbs)

•   Fusion proteins

•   Antibody fragments (fAbs)

•   Peptides

•   Stem cells

•   Vaccines

Pfanstiehl Brand Trehalose is available as USP-NF (United States Pharmacopoeia — National Formulary), EP (European Pharmacopoeia) and JP (Japanese Pharmacopoeia). Pfanstiehl also holds a US DMF for the Trehalose (T-104-4) product.

Available Package Sizes: 1kg, 5kg, 25kg, 50kg.

products table

More About This Company

Pfanstiehl Tradeshow Video

Vice-president of research and development (R&D) Dr Trevor Calkins discusses Pfanstiehl’s active pharmaceutical ingredients (API)...